臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"chiun hsu"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 26-75 of 356 (8 Page(s) Totally)
1 2 3 4 5 6 7 8 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-08-19T00:21:09Z	Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma	Lin C.-C.; Yeh K.-H.; Yang C.-H.; CHIUN HSU; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2022-08-19T00:21:08Z	Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers	Chen J.-P.; Lo Y.; Yu C.-J.; CHIUN HSU; Shih J.-Y.; Yang C.-H.
臺大學術典藏	2022-08-19T00:21:08Z	A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial	Cheng A.-L.; Chen P.-J.; Wu H.-B.; Tien H.-F.; Chao T.-Y.; Liu T.-W.; Li C.-C.; Liao Y.-M.; Chang M.-C.; Young J.-H.; Hsiao H.-H.; Lin T.-H.; Lin S.-F.; Wang M.-C.; Hwang W.-S.; Su I.-J.; CHIUN HSU; Hsiung C.A.
臺大學術典藏	2022-08-19T00:21:08Z	Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment	Lin Z.-Z.; CHIUN HSU; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2022-08-19T00:21:07Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	CHIUN HSU; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2022-08-19T00:21:07Z	Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer	Chang Y.-T.; Chang M.-C.; Wei S.-C.; Tien Y.-W.; CHIUN HSU; Liang P.-C.; Tsao P.-N.; Jan I.-S.; Wong J.-M.
臺大學術典藏	2022-08-19T00:21:07Z	Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma	Hsiao S.-M.; Chen C.-A.; CHIUN HSU; Lin H.-H.; Hsieh C.-Y.; Wei L.-H.
臺大學術典藏	2022-08-19T00:21:06Z	Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival	Shen Y.-C.; Hu F.-C.; Jeng Y.-M.; Chang Y.-T.; Lin Z.-Z.; Chang M.-C.; CHIUN HSU; Cheng A.-L.
臺大學術典藏	2022-08-19T00:21:05Z	Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway	Chen K.-F.; Yeh P.-Y.; CHIUN HSU; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:21:05Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Cheng A.-L.; CHIUN HSU; Wang D.-S.; Lu Y.-S.; Fan H.-H.; Ou D.-L.; Shen Y.-C.; Liang J.-D.; Liou J.-Y.; Yu S.-L.
臺大學術典藏	2022-08-19T00:21:04Z	Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B	Liou J.-Y.; Shyue S.-K.; Chang C.-C.; Golubovskaya V.M.; Shen T.-L.; Shen Y.-C.; CHIUN HSU; Kuo C.-C.; Ko B.-S.; Chang T.-C.; Chen C.-H.; Liu C.-C.
臺大學術典藏	2022-08-19T00:21:04Z	Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design	CHIUN HSU; Shen Y.-C.; Cheng C.-C.; Hu F.-C.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:21:04Z	Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma	Jan Y.-J.; Ko B.-S.; CHIUN HSU; Chang T.-C.; Chen S.-C.; Wang J.; Liou J.-Y.
臺大學術典藏	2022-08-19T00:21:04Z	Sorafenib for the treatment of hepatocellular carcinoma across geographic regions	CHIUN HSU; Shen Y.-C.; Cheng A.L.
臺大學術典藏	2022-08-19T00:21:03Z	Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: Experts'opinion	Chen P.-J.; Furuse J.; Han K.-H.; CHIUN HSU; Lim H.-Y.; Moon H.; Qin S.; Ye S.-L.; Yeoh E.-M.; Yeo W.
臺大學術典藏	2022-08-19T00:21:03Z	Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma	Cheng A.-L.; Ding Y.-H.; CHIUN HSU; Shao Y.-Y.; Chen P.-J.; Lin Z.-Z.; Shen Y.-C.; Hsu C.-H.
臺大學術典藏	2022-08-19T00:21:02Z	Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma	Whang-Peng J.; Cheng A.-L.; CHIUN HSU; Chen C.-M.
臺大學術典藏	2022-08-19T00:21:02Z	Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin	Cheng A.-L.; Lin C.-H.; Chang K.-J.; Kuo W.-H.; CHIUN HSU; Lee W.-C.; Liau J.-Y.; Huang C.-S.; Lu Y.-S.; Shao Y.-Y.; Kuo K.-T.; Hu F.-C.
臺大學術典藏	2022-08-19T00:21:01Z	Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma	Cheng A.-L.; Hsu C.-H.; Shen Y.-C.; CHIUN HSU; Lin Z.-Z.; Shao Y.-Y.
臺大學術典藏	2022-08-19T00:21:00Z	Overexpression of 14-3-3�` predicts tumour metastasis and poor survival in hepatocellular carcinoma	Liou J.-Y.; Ko B.-S.; Chang T.-C.; CHIUN HSU; Chen Y.-C.; Shen T.-L.; Chen S.-C.; Wang J.; Wu K.K.; Jan Y.-J.
臺大學術典藏	2022-08-19T00:21:00Z	Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil	Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.; Chen B.-B.; Hsu C.-H.; Hu F.-C.; CHIUN HSU; Yu C.-W.; Shen Y.-C.; Hsu C.-Y.
臺大學術典藏	2022-08-19T00:20:59Z	Increased expression of 14-3-3�] promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma	Shen T.-L.; Lee Y.-M.; Chen P.-F.; Wang J.; Shyue S.-K.; Liou J.-Y.; CHIUN HSU; Liang S.-M.; Hung Y.-L.; Chen S.-C.; Jan Y.-J.; Ko B.-S.; Liu T.-A.
臺大學術典藏	2022-08-19T00:20:59Z	Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era	Lu Y.S.; Cheng A.L.; Kuo W.H.; Chen I.C.; Lin C.H.; Huang C.S.; Lien H.C.; CHIUN HSU
臺大學術典藏	2022-08-19T00:20:58Z	Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma	Shao Y.-Y.; Lin Z.-Z.; CHIUN HSU; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:58Z	Antiangiogenic strategies for the treatment of hepatocellular carcinoma	CHIUN HSU; Shen Y.-C.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:57Z	Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy	Yang C.-H.; Hong R.-L.; Hsu C.-H.; Chengb A.-L.; Chang D.-Y.; Hu F.-C.; Shao Y.-Y.; CHIUN HSU; Lin Z.-Z.
臺大學術典藏	2022-08-19T00:20:57Z	Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study	Cheng A.-L.; Meng R.; Chao Y.; Hsieh T.-Y.; Huang W.-T.; Hwang W.-S.; Yu C.-W.; Hsieh R.-K.; Huo T.-I.; Yang T.-S.; CHIUN HSU
臺大學術典藏	2022-08-19T00:20:57Z	A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: A novel approach by using meta-regression	Shen Y.-C.; CHIUN HSU; Cheng C.-C.; Hu F.-C.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:56Z	Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression	Yeh K.-H.; Cheng C.-C.; Cheng A.-L.; Hu F.-C.; Shen Y.-C.; CHIUN HSU
臺大學術典藏	2022-08-19T00:20:55Z	Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy	Shau W.-Y.; Chen T.-J.; Yang S.-H.; Huang S.-M.; CHIUN HSU; Lu Y.-S.; Cheng A.-L.; Lin C.-H.; Kuo Y.-H.
臺大學術典藏	2022-08-19T00:20:55Z	Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems	Shen Y.-C.; Hsu C.-H.; Cheng A.-L.; CHIUN HSU; Lin Z.-Z.; Lu L.-C.; Shao Y.-Y.
臺大學術典藏	2022-08-19T00:20:55Z	Comparative microRNA detection from precursor-microRNA-transfected hepatocellular carcinoma cells by capillary electrophoresis with dual-color laser-induced fluorescence	Yang T.-H.; Ou D.-L.; CHIUN HSU; Huang S.-H.; Chang P.-L.
臺大學術典藏	2022-08-19T00:20:55Z	erratum: Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression (Gastric Cancer (2012) 15(265-280) DOI 10.1007/s10120-011- 0106-5)	CHIUN HSU; Shen Y.-C.; Cheng C.-C.; Cheng A.-L.; Hu F.-C.; Yeh K.-H.
臺大學術典藏	2022-08-19T00:20:54Z	The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines	Cheng A.-L.; Lu Y.-S.; Chen W.-W.; Chang D.-Y.; Huang S.-M.; Lin C.-H.; CHIUN HSU; Lin M.-H.; Huang C.-S.
臺大學術典藏	2022-08-19T00:20:54Z	Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients	Yeh K.H.; Hu F.C.; Chang S.Y.; Kao H.F.; Chen Y.C.; Chien S.F.; Chen I.C.; CHIUN HSU
臺大學術典藏	2022-08-19T00:20:53Z	Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma	Liu S.-H.; Cheng A.-L.; Lin C.-Y.; Chang C.-Y.; Lin K.-L.; CHIUN HSU; Ou D.-L.; Shen Y.-C.
臺大學術典藏	2022-08-19T00:20:53Z	Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway	Liou J.-Y.; CHIUN HSU; Cheng A.-L.; Lin L.-I.; Lee B.-S.; Chang Y.-C.; Ou D.-L.
臺大學術典藏	2022-08-19T00:20:53Z	14-3-3�` Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma	Wu Y.-M.; Liou J.-Y.; Wang J.; CHIUN HSU; Chen S.-C.; Liang S.-M.; Ko B.-S.; Jan Y.-J.; Liu T.-A.
臺大學術典藏	2022-08-19T00:20:52Z	Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group	Kim W.S.; Kwong Y.-L.; Suh C.; Lim S.T.; Cheng A.-L.; Chng W.-J.; Lee J.; Intragumtornchai T.; Kim S.J.; CHIUN HSU; Song Y.-Q.; Tay K.; Hong X.-N.; Cao J.; Kim J.S.; Eom H.S.; Lee J.H.; Zhu J.; Chang K.-M.; Reksodiputro A.H.; Tan D.; Goh Y.T.
臺大學術典藏	2022-08-19T00:20:51Z	Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies	Liu K.-L.; Liang P.-C.; Shih T.T.-F.; Chen C.-H.; CHIUN HSU; Wu C.-H.; Shih I.-L.; Chen B.-B.
臺大學術典藏	2022-08-19T00:20:51Z	Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size	Lai M.-S.; Yang J.C.-H.; Cheng A.-L.; Hsu C.-H.; Kuo R.N.-C.; Yeh Y.-C.; Shao Y.-Y.; CHIUN HSU; Shau W.-Y.; Lin Z.-Z.
臺大學術典藏	2022-08-19T00:20:50Z	Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan	Chang Y.-T.; Chang M.-C.; Huang K.-W.; Tung C.-C.; CHIUN HSU; Wong J.-M.
臺大學術典藏	2022-08-19T00:20:50Z	Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study	Cheng A.-L.; Chen P.-J.; Liu T.-W.; Chang C.-S.; Tien H.-F.; CHIUN HSU; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.
臺大學術典藏	2022-08-19T00:20:49Z	Reply	CHIUN HSU; Chen P.-J.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:48Z	Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivity	Cheng A.-L.; Wang H.-P.; Tsai H.-J.; Wu M.-S.; Tzeng Y.-S.; Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; CHIUN HSU
臺大學術典藏	2022-08-19T00:20:48Z	Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma	Chang M.-C.; Chen C.-H.; Liang J.-D.; Tien Y.-W.; CHIUN HSU; Wong J.-M.; Chang Y.-T.
臺大學術典藏	2022-08-19T00:20:47Z	A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma	Tak W.Y.; Yen C.-J.; Jeffers M.; Krissel H.; Kappeler C.; Rajagopalan P.; Hsieh W.-S.; Tay M.H.; Yeo W.; Park J.-W.; Poon R.T.P.; Rau K.-M.; CHIUN HSU; Yoon J.-H.; Lin C.-Y.; Choi H.J.; Heo J.; Lim H.Y.
臺大學術典藏	2022-08-19T00:20:46Z	H3K9 histone methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis	Wu P.-C.; Lu J.-W.; Yang J.-Y.; Lin I.-H.; Ou D.-L.; Lin Y.-H.; Chou K.-H.; Huang W.-F.; Wang W.-P.; Huang Y.-L.; CHIUN HSU; Lin L.-I.; Lin Y.-M.; James Shen C.-K.; Tzeng T.-Y.
臺大學術典藏	2022-08-19T00:20:46Z	Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review	Lim H.Y.; Kim J.S.; Orlando M.; Chen L.-T.; Chen J.-S.; CHIUN HSU; Oh D.-Y.; Park J.O.
臺大學術典藏	2022-08-19T00:20:45Z	The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia	Yang J.C.H.; Lai M.-S.; Cheng A.-L.; Cheng W.-F.; CHIUN HSU; Shao Y.-Y.; Yang Y.-Y.; Lai C.-L.; Shau W.-Y.; Kuo R.; Lin Z.-Z.; Kuo H.-Y.

Showing items 26-75 of 356 (8 Page(s) Totally)
1 2 3 4 5 6 7 8 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 52818658 Online Users : 643 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library